In a double-blind study, we examined the efficacy of allopurinol in the prevention of recurrent calcium oxalate calculi of the kidney. Sixty patients with hyperuricosuria and normocalciuria who had a history of calculi were randomly assigned to receive either allopurinol (100 mg three times daily) or a placebo. After the study, the placebo group had 63.4 percent fewer calculi (P less than 0.001), whereas the allopurinol group had 81.2 percent fewer calculi (P less than 0.001). During the study period, the mean rate of calculous events was 0.26 per patient per year in the placebo group and 0.12 in the allopurinol group. When the treatment groups were compared by actuarial analysis, the allopurinol group was found to have a significantly longer time before recurrence of calculi (P less than 0.02). We conclude that allopurinol is effective in the prevention of calcium oxalate stones in patients with hyperuricosuria. The large reduction in the frequency of calculi in the placebo group underscores the positive treatment bias that regularly occurs in trials of prophylaxis against renal calculi when historical controls are used.
This article has been cited by other articles:
HALL, P. M.
(2009). Nephrolithiasis: Treatment, causes, and prevention. Cleveland Clinic Journal of Medicine
76: 583-591
[Abstract][Full Text]
Heher, E. C., Thier, S. O., Rennke, H., Humphreys, B. D.
(2008). Adverse Renal and Metabolic Effects Associated with Oral Sodium Phosphate Bowel Preparation. CJASN
3: 1494-1503
[Abstract][Full Text]
Sutaria, S., Katbamna, R., Underwood, M.
(2006). Effectiveness of interventions for the treatment of acute and prevention of recurrent gout--a systematic review. Rheumatology (Oxford)
45: 1422-1431
[Abstract][Full Text]
Finkielstein, V. A., Goldfarb, D. S.
(2006). Strategies for preventing calcium oxalate stones.. CMAJ
174: 1407-1409
[Full Text]
Curhan, G. C.
(2005). A 44-Year-Old Woman With Kidney Stones. JAMA
293: 1107-1114
[Full Text]
Farell, G., Huang, E., Kim, S. Y., Horstkorte, R., Lieske, J. C.
(2004). Modulation of Proliferating Renal Epithelial Cell Affinity for Calcium Oxalate Monohydrate Crystals. J. Am. Soc. Nephrol.
15: 3052-3062
[Abstract][Full Text]
Teichman, J., Muldowney, F.P., Bataille, P., Presne, C., Fournier, A., Gavras, I., Borghi, L., Maggiore, U., Bushinsky, D. A.
(2002). Prevention of Recurrent Stones in Idiopathic Hypercalciuria. NEJM
346: 1667-1669
[Full Text]
Borghi, L., Schianchi, T., Meschi, T., Guerra, A., Allegri, F., Maggiore, U., Novarini, A.
(2002). Comparison of Two Diets for the Prevention of Recurrent Stones in Idiopathic Hypercalciuria. NEJM
346: 77-84
[Abstract][Full Text]
Morton, A. R., Iliescu, E. A., Wilson, J. W.L.
(2002). Nephrology: 1. Investigation and treatment of recurrent kidney stones. CMAJ
166: 213-218
[Full Text]
Koka, R. M., Huang, E., Lieske, J. C.
(2000). Adhesion of uric acid crystals to the surface of renal epithelial cells. Am. J. Physiol. Renal Physiol.
278: F989-F998
[Abstract][Full Text]
Heilberg, I. P.
(2000). Update on dietary recommendations and medical treatment of renal stone disease. Nephrol Dial Transplant
15: 117-123
[Full Text]
Emmerson, B. T.
(1996). The Management of Gout. NEJM
334: 445-451
[Full Text]
Uribarri, J., Oh, M. S., Carroll, H. J.
(1989). The First Kidney Stone. ANN INTERN MED
111: 1006-1009
[Abstract]
Previous
